1. [Auto-inducible expression system based on the SigB-dependent ohrB promoter in Bacillus subtilis].
- Author
-
Panahi R, Vasheghani-Farahani E, Shojaosadati SA, and Bambai B
- Subjects
- Amino Acid Sequence, Bacillus subtilis drug effects, Bacillus subtilis metabolism, Bacterial Proteins metabolism, Batch Cell Culture Techniques, Culture Media chemistry, Endo-1,4-beta Xylanases metabolism, Feedback, Physiological, Fermentation, Isopropyl Thiogalactoside analogs & derivatives, Isopropyl Thiogalactoside pharmacology, Molecular Sequence Data, Plasmids metabolism, Sigma Factor metabolism, Bacillus subtilis genetics, Bacterial Proteins genetics, Endo-1,4-beta Xylanases genetics, Gene Expression Regulation, Bacterial, Plasmids chemistry, Promoter Regions, Genetic, Sigma Factor genetics
- Abstract
The reliable production of heterologous proteins is important in the field of industrial biotechnology. This can be achieved by applying auto-inducible gene expression systems. The development of a Bacillus subtilis expression plasmid harboring SigB-dependent ohrB promoter was reported. The expression system was subjected to high cell density cultivation to produce xylanase as a stable model protein. The recombinant strain was cultured in a synthetic medium containing glucose as the carbon source. The exponential fed-batch feeding strategy was applied to prevent substrate inhibition. A sharp increase of xylanase activity (about 6-fold) at the end of the fermentation was observed as a result of sigma factor B (SigB) protein activation, supporting auto-inducibility of the expression system. For the control strain a specific induction of the xylanase activity was not observed. The recombinant strain was capable to offer a 5-fold increase in xylanase activity in comparison with the control strain. In addition, the constructed system displayed catabolite repression resistance ability. This SigB-dependent expression system can be considered as a biotechnology tool and an alternative to eliminate the cost of conventional inducers, e.g. isopropyl-β-galactopyranoside.
- Published
- 2014
- Full Text
- View/download PDF